C CVRX INC
| Market Cap | $237.07M |
| P/E Ratio | — |
| Forward P/E | -5.07 |
| Dividend Yield | — |
| Beta | 1.12 |
| 52W Range | $4.74 - $12.27 |
| # Hedge Funds | 1 |
| Sector | Healthcare |
| Industry | Medical Devices |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Mairs & Power Growth Fund Mairs & Power Inc | 0.01% | $1.01M | 142,456 | Reduce 1.72% |
Insider Trading
| Insider Name of the company insider who made the trade 13 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Adamson Philip B.Chief Medical Officer | Sale | 1,262 | $7.90 | $9.97K | 02 Mar 2026 | 27 Feb 2026 |
| OASHEIM JAREDCHIEF FINANCIAL OFFICER | Sale | 1,744 | $7.90 | $13.78K | 02 Mar 2026 | 03 Mar 2026 |
| VERRASTRO PAULCHIEF MKTG & STRAT OFFICER | Sale | 1,284 | $7.90 | $10.15K | 02 Mar 2026 | 03 Mar 2026 |
| John Robert AllenChief Revenue Officer | Sale | 3,964 | $7.90 | $31.33K | 02 Mar 2026 | 03 Mar 2026 |
| Hykes KevinPRES & CEO | Sale | 7,763 | $7.90 | $61.35K | 02 Mar 2026 | 03 Mar 2026 |
| Jain Mudit K. | Buy | 46,800 | $6.36 | $297.59K | 20 Feb 2026 | 23 Feb 2026 |
| Jain Mudit K. | Buy | 600 | $4.64 | $2.79K | 18 Feb 2026 | 18 Feb 2026 |
| JOHNSON & JOHNSON | Sale | 6,337 | $10.03 | $63.56K | 26 Nov 2025 | 01 Dec 2025 |
| JOHNSON & JOHNSON10% Owner/ 10% Owner | Sale | 2,200 | $10.06 | $22.13K | 24 Nov 2025 | 25 Nov 2025 |
| JOHNSON & JOHNSON | Sale | 500 | $10.00 | $5.00K | 21 Nov 2025 | 25 Nov 2025 |
| JOHNSON & JOHNSON | Sale | 1,000 | $10.00 | $10.00K | 12 Nov 2025 | 14 Nov 2025 |
| JOHNSON & JOHNSON | Sale | 200 | $10.00 | $2.00K | 07 Nov 2025 | 10 Nov 2025 |
| JOHNSON & JOHNSON | Sale | 52,332 | $10.21 | $534.31K | 06 Nov 2025 | 10 Nov 2025 |
Frequently Asked Questions
What is CVRX stock price today?
CVRX INC (CVRX) is currently trading at $9.01. The stock has a 52-week range of $4.74 to $12.27 and a market capitalization of $237.07M.
Is CVRX a good stock to buy in 2026?
CVRX INC has a P/E ratio of N/A (forward P/E: N/A), a dividend yield of none, and 1-year performance of -26.6%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling CVRX stock?
There have been 13 insider transactions for CVRX in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has CVRX stock performed over the past year?
CVRX INC (CVRX) has returned -26.6% over the past 12 months. The stock traded between $4.74 and $12.27 during this period, and is currently at $9.01.
Which hedge funds own CVRX (CVRX INC)?
1 tracked hedge funds currently hold CVRX in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is CVRX's market cap and valuation?
CVRX INC (CVRX) has a market capitalization of $237.07M. The trailing P/E ratio is N/A and forward P/E is N/A. The stock is classified in the Healthcare sector.
What is CVRX's revenue and profitability?
CVRX INC reported revenue of $56.65M with net income of N/A and a profit margin of N/A. The stock has a beta of 1.12.
What sector is CVRX in and who are its biggest institutional holders?
CVRX INC (CVRX) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.